Skip to main content
. 2016 May 27;8:230–234. doi: 10.1016/j.dib.2016.05.047

Fig. 2.

Fig. 2

Dose-dependent effect of recombinant rTREM-1/Fc fusion chimera (TREM-1/FC) (0.2, 0.8 and 1.6 µg/ml) on the expression of MMP-1 (Panel A) and MMP-9 (Panel B) in VSMCs isolated from asymptomatic (AS) and symptomatic (S) carotid plaques and treated with TNF-α (10 ng/ml). Data are presented as mean±SD (N=3). Relative expression was normalized to GAPDH. *p<0.05, **p<0.01, ***p<0.001, ****p< 0.0001.